Cargando…

The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders

PURPOSE: GSK3B and AKT1 genes have been implicated in the pathogenesis of a number of psychiatric and neurological disorders. Furthermore, their genetic variants are associated with response to antidepressant pharmacotherapy. As the evidence is still incomplete and inconsistent, continuing efforts t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levchenko, Anastasia, Losenkov, Innokentiy S, Vyalova, Natalia M, Simutkin, German G, Bokhan, Nikolay A, Wilffert, Bob, Loonen, Anton JM, Ivanova, Svetlana A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055890/ https://www.ncbi.nlm.nih.gov/pubmed/30050316 http://dx.doi.org/10.2147/PGPM.S171423

Ejemplares similares

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
por: Ochi, Taichi, et al.
Publicado: (2019)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients
por: Losenkov, Innokentiy S., et al.
Publicado: (2020)

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design
por: Geers, Lisanne M., et al.
Publicado: (2021)

NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder
por: Levchenko, Anastasia, et al.
Publicado: (2020)

Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression
por: Roschina, Olga V., et al.
Publicado: (2021)

The gender-specific association of rs334558 in GSK3β with major depressive disorder
por: Liu, Sha, et al.
Publicado: (2017)

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson’s Disease in central China
por: Yu, Lan, et al.
Publicado: (2014)

A New Paradigm to Indicate Antidepressant Treatments
por: Loonen, Anton J. M., et al.
Publicado: (2021)

Exploring Brain Derived Neurotrophic Factor and Cell Adhesion Molecules as Biomarkers for the Transdiagnostic Symptom Anhedonia in Alcohol Use Disorder and Comorbid Depression
por: Levchuk, Lyudmila A., et al.
Publicado: (2020)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
por: Mikhalitskaya, Ekaterina V., et al.
Publicado: (2023)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

Genetic polymorphisms of PIP5K2A and course of schizophrenia
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2020)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

The difference in serum proteomes in schizophrenia and bipolar disorder
por: Smirnova, Liudmila, et al.
Publicado: (2019)

Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens
por: Ochi, T., et al.
Publicado: (2023)

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia
por: Pozhidaev, Ivan V, et al.
Publicado: (2020)

Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders
por: Levchuk, Lyudmila A., et al.
Publicado: (2023)

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
por: Boiko, Anastasiia S., et al.
Publicado: (2019)

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations
por: Ivanova, Svetlana A, et al.
Publicado: (2016)

Neuron-specific enolase during the therapy in patients with alcohol use disorder and mood disorders
por: Levchuk, L., et al.
Publicado: (2021)

Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning
por: Ivanova, Svetlana A., et al.
Publicado: (2018)

Association of PIP4K2A Polymorphisms with Alcohol Use Disorder
por: Fedorenko, Olga Yu., et al.
Publicado: (2021)

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia
por: Geers, Lisanne M., et al.
Publicado: (2020)

Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
por: Kornetova, Elena G., et al.
Publicado: (2019)

The evolutionary old forebrain as site of action to develop new psychotropic drugs
por: Loonen, Anton JM, et al.
Publicado: (2018)

Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
por: Loonen, Anton JM, et al.
Publicado: (2020)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
por: Boiko, Anastasiia S, et al.
Publicado: (2020)

Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2021)

Clinical dynamics of anhedonia symptom in mood disorder and in alcohol use disorder
por: Roshchina, O., et al.
Publicado: (2021)

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
por: Mednova, Irina A., et al.
Publicado: (2020)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia
por: Fedorenko, Olga Yu, et al.
Publicado: (2015)

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2021)

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals
por: Kornetova, Elena G., et al.
Publicado: (2021)

SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia
por: Aftanas, Lyubomir I., et al.
Publicado: (2019)

Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding
por: Ivanova, Svetlana A., et al.
Publicado: (2016)

Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates
por: Loonen, Anton J. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_45l7iigl9bjin364lhuqagu6on